EUVIMEDEUVIMED entdecken
Crossref

Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells

Xinlin Lin, Mengsi Zheng, Kai Xiong, Fa Wang, Yu Chen, Liangnian Ji, Hui Chao iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Xinlin Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Schoo…. Hauptthemen laut MEDLINE: Ferroptosis, Ubiquitin-Protein Ligases, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Science Fund for Distinguished Young Scholars of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using photodynamic therapy (PDT) to trigger nonconventional cell death pathways has provided a new scheme for highly efficient and non-side effects to drug-resistant cancer therapies. Nonetheless, the unclear targets of available photosensitizers leave the manner of PDT-induced tumor cell death relatively unpredictable. Herein, we developed a novel Ru(II)-based photosensitizer, Ru-Poma. Possessing the E3 ubiquitin ligase CRBN-targeting moiety and high singlet oxygen yield of 0.96, Ru-Poma was demonstrated to specifically photodegrade endogenous CRBN, increase lipid peroxide, downregulate GPX4 and GAPDH expression, and consequently induce ferroptosis in cisplatin-resistant cancerous cells. Furthermore, with the deep penetration of two-photon excitation, Ru-Poma achieved drug-resistant circumvention in a 3D tumor cell model. Thus, we describe the first sample of the CRBN-targeting Ru(II) complex active in PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisUbiquitin-Protein LigasesDrug Resistance, NeoplasmAntineoplastic AgentsCisplatinPhotosensitizing AgentsPhotochemotherapyRutheniumHumansCell Line, TumorCoordination ComplexesPhotonsAdaptor Proteins, Signal Transducing

Substanzen

Ubiquitin-Protein LigasesAntineoplastic AgentsCisplatinPhotosensitizing AgentsRutheniumCRBN protein, humanCoordination ComplexesAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, P. R. China.

ORCID-Profile: Hui Chao

Förderung

  • Science Fund for Distinguished Young Scholars of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Lin, X., Zheng, M., Xiong, K., Wang, F., Chen, Y., Ji, L., & Chao, H. (2024). Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00545

Vancouver

Lin X, Zheng M, Xiong K, Wang F, Chen Y, Ji L, et al. Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00545

BibTeX
@article{Lin2024,
  author = {Lin, Xinlin and Zheng, Mengsi and Xiong, Kai and Wang, Fa and Chen, Yu and Ji, Liangnian and Chao, Hui},
  title = {Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00545}
}
Kostenlos starten →